Talaris Therapeutics and Greater Gift to Celebrate Clinical Trial Participants
Talaris Therapeutics and Greater Gift of Winston Salem, a non-profit that celebrates and seeks to increase diversity in clinical research, have partnered to recognize volunteers who participate in clinical trials.
In addition to providing for certificates to be sent to clinical trial participants, acknowledging their contribution to science and the advancement of medicine, Talaris’ partnership with Greater Gift will provide backpacks with meals for families who need them through Feeding America.
Read more about this partnership here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Twice-Yearly Lenacapavir Injections Significantly Reduce HIV Risk, PURPOSE 2 Trial Shows
November 13th 2024Full Phase III PURPOSE 2 trial results suggest that twice-yearly lenacapavir could revolutionize HIV prevention by offering a convenient and effective long-acting option for individuals at risk of infection.
